Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
3 Red-Hot Stocks That Could Continue to Beat the Market
06:30am, Thursday, 13'th Oct 2022
Investors are betting on these companies' revenue growth prospects.
These Are The Five Best And Worst Performing Large-Cap Stocks In September 2022
07:57pm, Monday, 10'th Oct 2022
September has been a tough month for the U.S. stock market historically, and this year was no different.
Moderna, Eli Lilly And This Biotechnology Stock Insiders Are Selling
11:52am, Monday, 10'th Oct 2022 Benzinga
The Nasdaq Composite tumbled by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s p
These 7 Biotech Stocks Are Set to Boom in 2023
06:15am, Monday, 10'th Oct 2022
Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good
2 Top Healthcare Stocks to Buy Right Now
01:35pm, Saturday, 08'th Oct 2022 The Motley Fool
Healthcare is about as sticky of a business model as you'll find.
Best Stocks To Buy For October 2022? 2 Healthcare Stocks In Focus
10:02am, Thursday, 06'th Oct 2022
2 top healthcare stocks to watch in October 2022.
Tracking William Nygren's Harris Associates Portfolio - Q2 2022 Update
04:49am, Thursday, 06'th Oct 2022 Seeking Alpha
Harris Associates' 13F portfolio value decreased from $75.90B to $62.85B this quarter. Read more to see about Harris Associates' holdings and trades for Q2 2022.
Apple Short Sellers Made $2B In Profits In September, And Shorts In This Biotech Stock Lost $307M
05:04pm, Wednesday, 05'th Oct 2022 Benzinga
The SPDR S&P 500 ETF Trust (NYSE: SPY) struggled in September, historically its worst month of the year.
The S&P 500 hit new lows, and many investors' year-to-date returns sank deeper into the red las
Final Trades: Lamar, Wynn, Eaton & more
02:15pm, Wednesday, 05'th Oct 2022
The "Halftime Report" traders give their top picks to watch for the second half.
REGN vs. RGEN: Which Stock Is the Better Value Option?
03:40pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
REGN vs. RGEN: Which Stock Is the Better Value Option?
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
02:23pm, Tuesday, 04'th Oct 2022 The Motley Fool
These biotech stocks are finding game-changing therapies, and their shares are up as a result.
Regeneron (REGN) Recently Broke Out Above the 20-Day Moving Average
01:35pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
01:15pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Regeneron's (REGN) top line is affected by negligible sales from REGEN-COV while lead drug Eylea faces stiff competition.
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
01:10pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Dupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine portfolio, which has become the primary top-line driver. Its R&D pipeline is strong.
REGN vs. RGEN: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 04'th Oct 2022
REGN vs. RGEN: Which Stock Is the Better Value Option?
